Peficitinib suppresses diffuse-type tenosynovial giant cell tumor by targeting TYK2 and JAK/STAT signaling.
Lu S, Cao C, Zhang W, Li J, Yang J, Huang Z, Wu Z, Liu B, Huang H, Wang H, Wang Y, Liu D, Zhang Z, Liu K, Yang G, Gong X, Dai H, Li Y, Dong E, Zhang X, Zhang Y.
Lu S, et al. Among authors: yang g.
Sci China Life Sci. 2025 Jan 8. doi: 10.1007/s11427-024-2790-7. Online ahead of print.
Sci China Life Sci. 2025.
PMID: 39808223